首页> 外文会议>World biomaterials congress >Synthesis and characterization of biodegradable polyurethanes for controlled drug release
【24h】

Synthesis and characterization of biodegradable polyurethanes for controlled drug release

机译:用于药物控制释放的可生物降解聚氨酯的合成与表征

获取原文

摘要

Polyurethanes made from degradable polyester and aliphatic diisocyanates were versatile polymers with good biocompatibility, biodegradability and desired mechanical properties, which could be used as biomaterials for tissue engineering and drug delivery. in this work, polyurethane acrylate (PUA) monomers synthesized from bifunctional hydroxy-terminated poly(epsilon-caprolactone) (PCL) with various molecular weights (1500,3300 or 5000) and alkyl diisocyanates (isophorone diisocyanate (IPDI)or 1,6-hexamethylene diisocyanate (HDI)) were functionalized with hydroxyethyl methacrylate. Six PUAs were prepared and characterized with FTIR, NMR and GPC. These monomers were polymerized under UV light to form six cross-linked PUA membranes, which were characterized with DSC, TGA and XRD. It showed that the membranes were stable under a temperature lower than 300oC. The PUAs with long chain PCL (≥3300) were found partially crystallized with melting points between 30 and 40 oC. Contact angle analysis and the swelling of membranes in water and THF were carried out. It was found that the membrane made from PCL(1500)/HDI was more hydrophilic. Therefore it degraded faster than other PUA membranes in both H2O2 and lipase solutions according to the weight-loss analysis. It lost nearly 40% of the weight after 7 days' incubation in H2O2 solution under 37oC with shaking. The PUA membranes were then loaded with tetracycline hydrochloride, a water soluble antibiotic to investigate their drug releasing profiles by monitoring the drug concentration in PBS. The results indicated that all membranes almost released the drug in a constant rate in the first 8 days. Among them two PUA membranes made from PCL(5000)/HDI and PCL(3300)/IPDI respectively releasing most of the loaded drug have potential to be used as biodegradable carriers for controlled drug release.
机译:由可降解聚酯和脂族二异氰酸酯制得的聚氨酯是通用聚合物,具有良好的生物相容性,生物降解性和所需的机械性能,可以用作组织工程和药物输送的生物材料。在这项工作中,由具有各种分子量(1500,3300或5000)的双官能羟基封端的聚ε-己内酯(PCL)和烷基二异氰酸酯(异佛尔酮二异氰酸酯(IPDI)或1,6-)合成的聚氨酯丙烯酸酯(PUA)单体六亚甲基二异氰酸酯(HDI))用甲基丙烯酸羟乙酯官能化。制备了六个PUA,并通过FTIR,NMR和GPC对其进行了表征。这些单体在紫外光下聚合形成六种交联的PUA膜,用DSC,TGA和XRD对其进行表征。结果表明,该膜在低于300oC的温度下是稳定的。发现带有长链PCL(≥3300)的PUA部分结晶,熔点在30至40 oC之间。进行了接触角分析以及膜在水和THF中的溶胀。发现由PCL(1500)/ HDI制成的膜更亲水。因此,根据重量损失分析,它在H2O2和脂肪酶溶液中的降解速度都快于其他PUA膜。在37oC的振荡条件下于H2O2溶液中孵育7天后,它损失了近40%的重量。然后在PUA膜上加载四环素盐酸盐(一种水溶性抗生素),以通过监测PBS中的药物浓度来研究其药物释放曲线。结果表明,所有膜在头8天几乎都以恒定速率释放药物。其中由PCL(5000)/ HDI和PCL(3300)/ IPDI制成的两种分别释放大部分负载药物的PUA膜有潜力用作可控药物释放的可生物降解载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号